Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-02 Purchase | 2022-05-03 4:12 pm | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 45,000 | $2.471 | $111,195 | 111,250 (Direct) | View |
| 2021-06-10 Purchase | 2021-06-10 4:57 pm | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 20,000 | $5.69 | $113,800 | 66,250 (Direct) | View |
| 2020-08-26 Sale(A) | 2020-08-28 5:11 pm | Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner | 148,700 | $8.108 | $1,205,660 | 5,819,383 (Direct) | View |
| 2020-08-25 Sale | 2020-08-27 7:06 pm | Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner | 164,488 | $8.0716 | $1,327,684 | 5,819,383 (Direct) | View |
| 2020-06-30 Sale | 2020-06-30 5:54 pm | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 13,000 | $7.35 | $95,550 | 26,250 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-01-15 Tax Withholding | 2022-02-11 6:34 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 827 | $4.24 | 238,695 (Direct) | View |
| 2022-01-03 Tax Withholding | 2022-01-05 7:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 8,835 | $4.62 | 256,304 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:13 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 173,333 | $0 | 256,304 (Direct) | View |
| 2022-01-03 Tax Withholding | 2022-01-05 7:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 3,097 | $4.88 | 256,304 (Direct) | View |
| 2022-01-03 Tax Withholding | 2022-01-05 7:12 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 11,845 | $4.62 | 413,522 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:12 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 251,333 | $0 | 413,522 (Direct) | View |
| 2022-01-03 Tax Withholding | 2022-01-05 7:12 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 3,919 | $4.88 | 413,522 (Direct) | View |
| 2022-01-03 Tax Withholding | 2022-01-05 7:12 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 26,432 | $4.62 | 2,426,686 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:12 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 563,333 | $0 | 2,426,686 (Direct) | View |
| 2022-01-03 Tax Withholding | 2022-01-05 7:12 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 36,319 | $4.88 | 2,426,686 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:11 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:11 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:10 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:09 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:08 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 5:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 55,500 | $0 | 1,924,807 (Direct) | View |
| 2021-09-28 Tax Withholding | 2021-09-30 5:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 27,750 | $6.5 | 1,924,807 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 5:45 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 6,667 | $0 | 177,535 (Direct) | View |
| 2021-09-28 Tax Withholding | 2021-09-30 5:45 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 2,839 | $6.5 | 177,535 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 5:43 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 6,667 | $0 | 94,485 (Direct) | View |
| 2021-09-28 Tax Withholding | 2021-09-30 5:43 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 2,306 | $6.5 | 94,485 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-25 9:30 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 20,000 | $1.5 | 46,250 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-25 9:30 pm | 2016-04-13 2021-04-13 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 20,000 | $0 | 46,250 (Direct) | View |
| 2021-01-19 Tax Withholding | 2021-01-19 6:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 808 | $6.68 | 89,751 (Direct) | View |
| 2021-01-15 Tax Withholding | 2021-01-19 6:23 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 686 | $6.48 | 169,952 (Direct) | View |
| 2021-01-15 Tax Withholding | 2021-01-19 6:23 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 994 | $6.68 | 169,952 (Direct) | View |
| 2021-01-19 Tax Withholding | 2021-01-19 6:21 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 1,685 | $6.68 | 116,062 (Direct) | View |
| 2021-01-19 Tax Withholding | 2021-01-19 6:19 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 5,611 | $6.68 | 1,894,181 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:42 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:41 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:40 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:39 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:38 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:37 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 54,334 | $0 | 150,747 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-06 4:37 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 2,739 | $5.8 | 150,747 (Direct) | View |
| 2021-01-03 Option Award | 2021-01-06 4:34 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 573,333 | $0 | 2,268,792 (Direct) | View |
| 2021-01-03 Tax Withholding | 2021-01-06 4:34 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 16,973 | $5.8 | 2,268,792 (Direct) | View |
| 2021-01-03 Tax Withholding | 2021-01-06 4:34 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 31,545 | $5.63 | 2,268,792 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:28 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 149,450 | $0 | 168,559 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-06 4:28 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 2,787 | $5.8 | 168,559 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:26 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 169,750 | $0 | 261,632 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-06 4:26 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 2,773 | $5.8 | 261,632 (Direct) | View |
| 2021-01-04 Ownership | 2021-01-06 4:22 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 0 | $0 | 191,146 (Direct) | View |
| 2021-01-04 Ownership | 2021-01-06 4:19 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 0 | $0 | 398,682 (Direct) | View |
| 2020-09-15 Option Award | 2020-09-16 5:21 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 4,500 | $0 | 97,873 (Direct) | View |
| 2020-09-15 Tax Withholding | 2020-09-16 5:21 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 1,557 | $6.25 | 97,873 (Direct) | View |
| 2020-09-15 Option Award | 2020-09-16 5:18 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 55,500 | $0 | 1,742,363 (Direct) | View |
| 2020-09-15 Tax Withholding | 2020-09-16 5:18 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 19,192 | $6.25 | 1,742,363 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-03 5:47 pm | 2021-03-31 2030-03-31 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-01-19 Tax Withholding | 2020-01-21 5:39 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 3,195 | $7.18 | 1,704,312 (Direct) | View |
| 2020-01-19 Tax Withholding | 2020-01-21 5:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 2,044 | $7.18 | 92,840 (Direct) | View |
| 2020-01-03 Option Award | 2020-01-03 8:03 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-01-03 Tax Withholding | 2020-01-03 8:01 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 6,782 | $7.77 | 2,052,507 (Direct) | View |
| 2020-01-03 Option Award | 2020-01-03 8:01 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 498,333 | $0 | 2,052,507 (Direct) | View |